us sales Thank of you, sequential pleased to XXXX. joining David, of XX.X% on we third quarter with for solid thanks are the report today. and growth growth trajectory second over everyone to the in back I'm quarter the
quarter over to our addition, last of third XX.X% for benefit period XXXX the the revenue increased the sales In same without year China. of
We overcome these the multi-channel last in war. The temporary our growth we illustrated discussed revenue the quarter, we dental Ukraine for we both second third and reflects as on XXXX. sequential sales fact year-over-year of successful in challenges year, revenue China by and challenges quarter in and fronts growth part strategy. decentralized in large in the of achieved quarter our Russia, international to domestic segment part, the faced this situation challenging As the have, due believe both
over United America, distributors announcing to to sell to grow strategic within increasingly market. XX XX% approximately as of to States, bring areas domestic the or look customers, to We as our dentistry we to their and respective additional DSOs. the growth. working South distribution through years. as as international which on we networks agreements help add specialized are especially Europe. continue market partners in XX% accelerate and across current an dental important In XX% our is will of DSOs we new penetration Importantly, network we XX% continue channel believe in to third-party such forward Africa, well dentistry Asia, aesthetics, and DSO organizations dental dental international large distribution dental expected further next implant that markets, The build of role service the play to
cash we to within a flow on So to solid dental standalone generate summarize, basis. our business, continue
grow economies the of from Overall, revenues, remains As our to due we and expect disposables. we nature margins to our recurring dental our continue strong. benefit to on business high scale
We are continue. expect instruments interest the encouraged momentum increased dental by in to our and our
to Turning the to System our CathCheck Medical the CompuFlo Verification our around Epidural System. commercial and segment, advance we continued efforts
activities, marketing Epidural and As a systems in result System CompuFlo hospitals' management sales our our pain focused clinics. healthcare of key we trialed and have
capability CompuFlo based As academy an in University CathCheck of Kentucky. and example, Epidural Health, in August, its the a adoption the Louisville, the System of leading system at we announced health
our in We each year and in introducing strategy the With and validation to care. sign, of CompuFlo Kentucky. by from and system new delivery, four as million the pain, six the owns institution medical UofL sales, providing This room. to important X.X the patient growing acute labor medical is not Health across each care also of market. more are patients three another become execute but a validation within we we operates centers, we benefit hospitals standard operating only leading than departments: health and the distinct state
we of targeting teaching part As sales several our tier one strategy, are university hospitals.
believe will institutions. Top names, the begin sales reduce greater in larger, these it the among we with penetrate are add hospitals these of as and credibility the to We XX that of some cycle recognized more Some nation. smaller
pipeline a institutions. hospitals Our discussions with is we number and advancing sales are healthcare and of solid
commence provide these further we as formal with as will institutions. commercial We respective sales soon updates
hospitals, sports reported and the the million specialty not pain segment market We also our System, centers. than includes XX segments. medicine procedures the Epidural centers, twice management more Epidural to delivery targeting which is and continue With introduce of also market CompuFlo outpatient centers, over the pain each year, size but market, only labor
healthcare payment and American payers issuance a payment as code as who on billing our the goes for This of Association. use The the Medicaid, announced recently pathways effect by Code Medicare personnel health CPT well we code allow such to and X, discretionary into for choose as Importantly, from commercial XXXX. January plans. coverage technology will Medical and
aiding rollout the process clinics. will by Specifically, particular, our we decision believe pain in that private reimbursement commercial financial accelerate within
We CPT are this cleared code take to the implemented of be XXXX. in reimbursement plan our quarter that will advantage of actively new preparing first AMA
sales are our to our also of direct addition channels, network expanding we In partners. distribution
over United On hospitals, East a bringing forward specialty CTI clinics, with well proven the medical as and our devices. CTI, partner, products in East sales years Greece, equipment. We in look heels leading medical in record medical is a regions leading extensive announced of devices Coast new rollout. consumables. of of our introducing provider of the the and as an of distributors track field the new healthcare international of relationships experience as They launching force, CPT We August, ideal is commercial code, a a additional medical believe and bring Midwest In our a F&M we devices receiving partnership new and successful Midwest to with sizable and the having record, pain of XX partner States. equipment Coast advance announcing track physicians, distributor Feed, we
much materials, our corporate more. and effective, to CompuFlo in sales Epidural We invested the be videos, more videos, build marketing education, provide CathCheck including tools for awareness to initiatives and system representatives and our training digital also with marketing brand the heavily brand have literature,
the large for to cost Medical CPT continue addressable market, care. We safety factors, the will segment convenience ultimately the CompuFlo and driven coupled the standard provider, by cost was code a not represents believe lead considerations issuance only savings. by with a the the and of recent These to driven of becoming
important financial Let undertaken. me now some initiatives discuss take we to a moment have
quarter, resources medical last the company. continue towards announced As we reallocate to represents we additional believe segment, the of future our which
of in third same the and time, expenses our reduction corporate the in dental focus third have party quarter, rate. which certain While on evident segment. a we the distribution number is overhead increasing in and the of avenues our burn DSO reduced in operating At
shareholder We provide Combined which recurring towards high we believe expect long-term market hand help million cash the drive to reductions cost well-positioned benefits instruments. performance we are strategy, significant us drive capital revenue. business sufficient come. margin to of quarter with and both our for the should no our to these activities improved provides on revenue, ended around accelerating see including grow which the value We executing years us and with to medical debt, our continue quarters, continue continued approximately as to disposables, which $X.X coming in we of dental
to pursuing Given new our we strong indications. new are also cash and position, instruments planning launch are
associated the company the the will for our effective which with and labor positioned in in as industry, risk of with the growth providing confident quarters. Epidural of positive potential have of Epidural well the We transform we believe care patients we reducing pain by for market and become pain the costs. system, relief, remain coming summarize, standard complications the ultimately delivery, CompuFlo and significant to management as while So, procedures
Importantly, we seeding with and Europe, our centers, the the within CompuFlo medical a management of hospitals, have clinics States number key are of with to to and the contribute this pain success. Instrument will the results months. begun believe and Epidural United financial in CPT our market quick provide three along for of we financial other undertaking At long-term point, recap steps like issuance our a I'd
excluding as market, increased revenue Securities compared no approximately XXXX, increased expanded our discussion, million and XX, approximately XXXX. XXXX for Total been X.X domestic detailed revenue revenue and Dental September three-months we was approximately approximately X.X Dental in versus more compared the increased which China for domestic approximately new a to partnership from September the XX-Q, quarter global recorded Chinese XX, please revenue company The refer with our dental Commission. as regulatory to related the of Form $XXX,XXX, gross results, year. nine-month marketing well has for and general, $XX,XXX and third For third Medical the increased period. reduced $XXX,XXX quarter last the third XXXX, $X consolidated were respectively. same and the million ended revenue including and approximately with the filed the administrative [ph] also period same and Exchange XXX,XXX approximately to the ended international the $X.X million increase time, of At XXXX, and decreased and increase million, of services. we months for million for revenue certain $XX,XXX. control, quality months September which a expenses, $X.X The fees to XX, as approximately expenses three the the Consolidated other decreased $X.X salaries during and result was XXXX. for profit as selling, XXXX for professional ended Consolidated XX, expenses, other versus million employee warehousing, quarter [$XXX,XXX] in of three approximately September the XXXX. distributors.
and X the the XX, for medical segments. our the mentioned $X.X towards and approximately XXXX, additional of three million three XX, September focus ending increased we and $XXX,XXX approximately approximately expenses ended months respectively. The As million resources million for of September the decrease capital and and our working $X.XX on to third Scientific respectively. I the Consolidated delay or million in and earlier, operations respectively. party for dental XXXX were approximately and The System. XXXX versus The approximately have equivalents share September and Milestone of and On certain XXXX research reallocated XXXX months three $X $XXX,XXX, distributors XX, had enhancement XX, $XX.X to XXXX million $XX.X XX, Anesthesia STA of XXXX related cash loss loss was is $XXX,XXX XXXX. Tooth Single cash from working development approximately December was capital of per months September net ending
the For million flows of and months XXXX, approximately ended million, X.X used XXXX X.X respectively. cash we September operating nine in activities XX, and had
dental platform to medical drive scalable highly effective wrap and believe developed within So, cost divisions. have our up, to both growth we a and we
segment, the XXXX. back growing with interest the take of disposals in trajectory are believe our the witnessing growth in on XX.X% excluding solid dental XX.X% second for and to last the sequential quarter Within over the advantage instrument XXXX of opportunities are our are quarter over period market. sales available same growth to a We sales quarter, and well-positioned we the our both we in we of to increased third compared year, China. Year third of year, revenue
continue front. solid can a time, initiatives also this grow will expanded that support partners, business forward code, At list to built the sales remain our not standalone see, reimbursement Within help we structure our our to fund of same and streamline you segment, the stream growth, the a that and shareholder added value. to initiatives As until but we becomes formal hospitals, our distribution steady dental to continue look of a to have only planned continue our contribute basis. and new the cash pipeline implementation segment which to driving we within on on Medical on provide believe revenue will operating CPT self-sustaining segment flow will Medical committed our our
and today. At would outlook We like providing unfold. as encouraged the questions. to up I'd by the you for are developments updates thank of the call to further like look the this open business to point, Operator? we call joining forward to